BACKGROUND: The efficacy of RTS,S/AS01 as a vaccine for malaria is being tested in a phase 3 clinical trial. Early results show significant, albeit partial, protection against clinical malaria and severe malaria. To ascertain variations in vaccine efficacy according to covariates such as transmission intensity, choice of adjuvant, age at vaccination, and bednet use, we did an individual-participant pooled analysis of phase 2 clinical data. METHODS: We analysed data from 11 different sites in ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
If you are the owner of this record, you can report an update to it here: Report update to this record